KKR & Co. Inc. (NYSE:KKR) Stake Decreased by ValueAct Holdings L.P.

ValueAct Holdings L.P. reduced its stake in shares of KKR & Co. Inc. (NYSE:KKR) by 36.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,207,208 shares of the asset manager’s stock after selling 697,600 shares during the period. KKR & Co. Inc. accounts for about 3.6% of ValueAct Holdings L.P.’s investment portfolio, making the stock its 7th largest position. ValueAct Holdings L.P. owned 0.14% of KKR & Co. Inc. worth $127,047,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of KKR. Gilbert & Cook Inc. lifted its holdings in shares of KKR & Co. Inc. by 5.8% during the 4th quarter. Gilbert & Cook Inc. now owns 14,530 shares of the asset manager’s stock worth $1,204,000 after acquiring an additional 792 shares during the period. Coldstream Capital Management Inc. purchased a new position in shares of KKR & Co. Inc. during the 4th quarter worth about $255,000. SageView Advisory Group LLC purchased a new position in shares of KKR & Co. Inc. during the 4th quarter worth about $357,000. Nomura Asset Management Co. Ltd. lifted its holdings in shares of KKR & Co. Inc. by 30.4% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 195,442 shares of the asset manager’s stock worth $16,192,000 after acquiring an additional 45,577 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in KKR & Co. Inc. during the 4th quarter worth approximately $239,000. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the transaction, the insider now directly owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, major shareholder Kkr Group Partnership L.P. sold 2,554,644 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $18.85, for a total transaction of $48,155,039.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now owns 25,260,971 shares in the company, valued at $650,470,003.25. The disclosure for this sale can be found here. Company insiders own 39.34% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. TD Cowen increased their target price on shares of KKR & Co. Inc. from $145.00 to $154.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. JMP Securities increased their target price on shares of KKR & Co. Inc. from $115.00 to $135.00 and gave the stock a “market outperform” rating in a research report on Thursday, August 1st. Citigroup increased their target price on shares of KKR & Co. Inc. from $130.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, August 2nd. Hsbc Global Res raised shares of KKR & Co. Inc. to a “strong-buy” rating in a research report on Wednesday, September 18th. Finally, The Goldman Sachs Group increased their target price on shares of KKR & Co. Inc. from $123.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $128.27.

KKR & Co. Inc. Stock Performance

KKR & Co. Inc. stock opened at $132.58 on Tuesday. The stock has a market cap of $117.65 billion, a P/E ratio of 29.73, a price-to-earnings-growth ratio of 0.99 and a beta of 1.62. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86. The stock has a 50 day moving average of $119.21 and a 200-day moving average of $108.15. KKR & Co. Inc. has a 52 week low of $53.72 and a 52 week high of $134.85.

KKR & Co. Inc. (NYSE:KKR) last released its earnings results on Wednesday, July 31st. The asset manager reported $1.09 EPS for the quarter, beating the consensus estimate of $0.89 by $0.20. The company had revenue of $4.17 billion during the quarter, compared to analysts’ expectations of $1.07 billion. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. During the same period in the prior year, the business posted $0.58 EPS. On average, analysts expect that KKR & Co. Inc. will post 4.01 EPS for the current fiscal year.

KKR & Co. Inc. Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 12th were paid a dividend of $0.175 per share. This represents a $0.70 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Monday, August 12th. KKR & Co. Inc.’s dividend payout ratio (DPR) is currently 15.70%.

KKR & Co. Inc. Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.